This inventor holds 6 USPTO granted patents and 9 published patent applications. Top assignees: Albert Einstein College of Medicine, Icahn School of Medicine at Mount Sinai. Active years: 2011-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- (2023)
- New York, NY (US) (2011 - 2024)
Company Filing History:
4 out of 514 
2 out of 538 
Years Active: 2011-2024
Title: Inventor Profile: Paul S. Frenette
Introduction
Paul S. Frenette is a distinguished inventor based in New York, NY, with a remarkable portfolio comprising five patents. His innovative contributions predominantly focus on advancements in hematopoietic stem cell research and treatment methodologies for various diseases, including cancer and sickle cell disease.
Latest Patents
Among his latest patents, one noteworthy invention involves methods for expanding hematopoietic stem cells using revitalized mesenchymal stem cells. This patent details a process of revitalizing mesenchymal stem cells (MSC) maintained in culture, achieved by transducing the MSC with vectors encoding a specific gene combination. Furthermore, it elaborates on the co-culturing of revitalized MSC with hematopoietic stem cells to enhance their efficacy.
Another significant patent granted to Frenette focuses on methods of treatment by targeting VCAM1 and MAEA. This patent features antibodies and antibody fragments designed to inhibit the activities of vascular cell adhesion molecule 1 (VCAM1) and/or macrophage erythroblast attacher (MAEA). It also includes formulations and kits containing these antibodies, aimed at treating cancers, sickle cell disease, and Polycythemia Vera.
Career Highlights
Throughout his career, Paul S. Frenette has made substantial contributions to medical research and innovation. He has worked at reputable institutions, including Albert Einstein College of Medicine and Mount Sinai School of Medicine, where his research has paved the way for new therapeutic approaches in hematology and oncology.
Collaborations
In his professional journey, Frenette has collaborated with esteemed colleagues, notably Sandra Pinho and Qiaozhi Wei. These collaborations have likely enriched his research, combining diverse expertise to drive forward advancements in stem cell applications and targeted cancer therapies.
Conclusion
Paul S. Frenette stands out as a prolific inventor whose dedication and innovative spirit have led to significant breakthroughs in medical science. With a solid foundation of patents and impactful collaborations, he continues to influence the field of hematopoietic stem cell research and treatment modalities, contributing to improved outcomes for patients facing serious health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile